IDEXX LABORATORIESIDEXX LABORATORIESIDEXX LABORATORIES

IDEXX LABORATORIES

No trades
See on Supercharts

IX1 fundamentals

IDEXX LABORATORIES financial statements, including revenue, expenses, profit, and loss

The total revenue of IX1 for the last quarter is 869.73 M CHF, and it's 14.58% higher compared to the previous quarter. The net income of Q1 24 is 212.52 M CHF.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth